GLP-1 GLP-1 agents support weight loss by curbing appetite and regulating blood sugar levels
Vigorous running, heavy squats and deadlifts, and HIIT workouts all increase intra-abdominal pressure significantly
When removing from cold storage, allow the vial to equilibrate to room temperature before opening
Research continues to explore the broader therapeutic potential of GLP-1, including its effects on the cardiovascular system, brain function, and its potential role in the treatment of conditions beyond type 2 diabetes, such as Parkinson's disease and Alzheimer's disease
According to the World Health Organisation (WHO), obesity has nearly tripled, emphasising the urgent need for effective management strategies such as glucagon-like peptide 1 (GLP-1) analogues